Publication: Assessment of Disease Activity in Large-vessel Vasculitis: Results of an International Delphi Exercise
| dc.contributor.author | DİRESKENELİ, RAFİ HANER | |
| dc.contributor.authors | Aydin, Sibel Z.; Direskeneli, Haner; Merkel, Peter A.; on behalf of the International Delphi on Disease Activity Assessment in Large-vessel Vasculitis | |
| dc.date.accessioned | 2022-03-02T05:39:51Z | |
| dc.date.accessioned | 2026-01-11T15:08:42Z | |
| dc.date.available | 2022-03-02T05:39:51Z | |
| dc.date.issued | 2017-12 | |
| dc.description.abstract | Objective. To arrive at consensus for candidate outcomes for disease activity assessment in large-vessel vasculitis (LVV) in clinical trials. Methods. A Delphi survey including 99 items was circulated among international experts for 3 rounds. Results. Fifty-seven items were accepted for both giant cell arteritis and Takayasu arteritis. Sixty-seven percent of experts voted to have a common approach for both diseases with additional disease-specific items such as weight loss, scalp tenderness/necrosis, morning stiffness, dizziness, visual symptoms, and imaging. Conclusion. This study highlights similarities and differences in experts’ perspectives for assessing clinical activity in LVV and may guide a consensus-driven core set of validated outcomes. | |
| dc.identifier.doi | 10.3899/jrheum.161269 | |
| dc.identifier.issn | 0315-162X, 1499-2752 | |
| dc.identifier.issue | 12 | |
| dc.identifier.pages | 1928-1932 | |
| dc.identifier.uri | https://hdl.handle.net/11424/218554 | |
| dc.identifier.volume | 44 | |
| dc.language.iso | eng | |
| dc.relation.uri | http://www.jrheum.org/lookup/doi/10.3899/jrheum.161269 | |
| dc.title | Assessment of Disease Activity in Large-vessel Vasculitis: Results of an International Delphi Exercise | |
| dc.title.alternative | Assessment of Disease Activity in Large-vessel Vasculitis | |
| dc.type | article | |
| dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1
